The Esthetic Clinics Clinical Research Organization (TECCRO) is not just a Clinical Research Organization (CRO); it is a pioneering extension of The Esthetic Clinics, deeply committed to understanding and fulfilling the needs of both patients and the broader industry. Where TECCRO relentlessly focuses on employing distinct cutting edge methodology and maintaining unwavering ethical research focus on patient centric approach. We at TECCRO strive to set new benchmarks in the field, ensuring that our work not only meets but exceeds the expectations of all stakeholders thereby providing exemplary services thus alleviating human health.
At TECCRO, our relentless pursuit of excellence and integrity is at the core of everything we do. Our primary mission is to provide exemplary clinical research services that adhere to the highest international standards while also upholding stringent ethical guidelines. We believe that by doing so, we can make a significant contribution to the improvement of human health on a global scale. Our team is dedicated to embracing and integrating the latest innovative technologies and methodologies to meet the ever-evolving public health demands. This commitment ensures that we remain a reliable partner to pharmaceutical, biotechnology, and medical device firms, facilitating the ethical advancement of safe and effective products into the market. And that the society benefits utmost from these services.
TECCRO stands as the top CRO in Mumbai, a distinction that we have earned through our multifaceted approach and diverse expertise. Unlike many organizations that may focus solely on a specific area of research, TECCRO prides itself on being versatile as compared to other CROs. Our domain expertise includes, but is not limited to, facial surgery, plastic surgery, dermatology, cosmetic surgery, cosmetology, and esthetics. However, our capabilities are not confined to these areas alone. We are open to and actively seek collaboration with pharmaceutical and biotech companies for conducting clinical trials in fields aligned with our expertise. This diversity not only sets us apart from other CROs but also underscores our commitment to driving innovation and providing clinically proven, advanced solutions.
Our research initiatives are driven by an unwavering commitment to innovation. We believe that the integration of cutting-edge technologies and evidence-based practices is essential for advancing healthcare. TECCRO’s approach is not merely staying abreast with industry standards; it is about setting new ones. We aim to empower other organizations by offering research-backed, quality-driven advanced products and processes that enable them to stand out in a competitive market. This is achieved through our rigorous and systematic approach towards research, ensuring that every study we conduct is of the highest quality and of ethical relevance.
One of the key differentiators of TECCRO when compared to other CROs is the involvement of highly qualified clinicians in our trial processes. These experts bring a wealth of experience and knowledge, ensuring that every patient involved in our trials receives the most advanced and effective treatments available. Patient safety is our utmost priority, as we adhere strictly to ethical principles in all our endeavors. This dedication to ethical conduct is not just a regulatory requirement for us; it is a core value that drives our entire operation. Clinicians and Research team at TECCRO undergo collaborative dynamic meeting prior conducting clinical trials for providing high quality services and better patient outcomes.
We understand that customer satisfaction is paramount, and it is a driving force behind everything we do. At TECCRO, we continually strive to enhance our research capabilities by integrating the latest technologies and staying abreast of the latest developments in the field. Our presence in over six major cities across India—Kolkata, Mumbai, Hyderabad, Chennai, Bengaluru, and Delhi—provides us with access to diverse demographics, ensuring that our trial outcomes are robust and reflective of a wide range of populations. This geographical reach allows us to conduct comprehensive studies that are not only scientifically rigorous but also relevant to real-world settings.
To further ensure the integrity and precision of our trials, TECCRO has an in-house, registered Ethics Committee that is certified by both the Central Drugs Standard Control Organization (CDSCO) and the Drugs Controller General of India (DCGI). This committee plays a crucial role in overseeing the ethical aspects of our trials, ensuring that all studies are conducted with the highest level of precision and are in strict adherence to the ethical standards. The presence of this committee within our organization underscores our commitment to maintaining the highest standards of ethical conduct in all our research activities.
Innovation in research is not just an aim at TECCRO but also an unwavering promise of applying it on a daily basis. To foster a culture of ongoing learning and collaboration, we host monthly Journal Club meetings for our professionals. These meetings provide a platform for our team to discuss and critically evaluate the latest research published in top-tier academic and scientific journals. This collaborative approach not only keeps our team informed about the latest advancements but also encourages the exchange of ideas and insights that can lead to new and innovative approaches in our research.
Our dedication to service excellence has led to the successful initiation of six investigator-led clinical trials and four industry-sponsored trials. These achievements are a testament to our capability and commitment to advancing medical science. However, our work does not stop at conducting trials. We are equally committed to ensuring that the knowledge and findings generated through our research are disseminated to the broader scientific community and the public. We achieve this by publishing our research articles in top-tier, indexed journals that are recognized globally. This dissemination of information is crucial for advancing the field of healthcare and ensuring that the benefits of our research are realized by society at large.
Between 2017 and 2019, TECCRO achieved a significant milestone by backing both US and Indian patents for our innovative intradermal hair growth formulation. This groundbreaking formulation also received approval from the Indian FDA, further validating the quality and efficacy of our research. The journey of TECCRO, however, began much earlier, in 2006, at the Indian Institute of Technology (IIT) Mumbai, where the phenomenon of hair loss was first uncovered in animal model. This initial discovery sparked a commitment to research that has continued to drive our efforts to advance the healthcare industry through innovation.
In today’s fast-paced world, If we do not claim the work, some people will take the novelty idea for their advantage and thus acknowledging the work becomes necessary. Our research and achievements have been featured in various newspapers and blogs across social media, earning us widespread recognition and acclaim. This visibility has helped to establish TECCRO as a leader in the field of clinical research, a position we hold with pride and responsibility.
At TECCRO, we believe that while traditional CROs may follow established paths, TECCRO is here to lead the way. We are committed to pushing the boundaries of what is possible in clinical research, continually seeking new ways to improve healthcare outcomes for the benefit of society. We invite you to join us on this journey as we continue to advance healthcare and make a lasting impact on the world.